HYLORIS DEVELOPMENTS S.A.

City:

Liège

Country:

Belgium

Published Applications:

Last publication date:

2025-04-03

Patent Grants:

Last grant date:

2025-07-15

Top Inventors for applications by HYLORIS DEVELOPMENTS S.A.

These are the the leading inventors for applications assigned to HYLORIS DEVELOPMENTS S.A.:

Somberg John 2 Lake Bluff, IL United States
John Somberg 2 Lake Forest, IL United States
L. Diane Bruce 1 Ft. Worth, TX United States
John Somberg 1 Lake Bluff, IL United States

Mary Beth G. Erstad 1 Plymouth, MN United States
Mohammad Alkhalili 1 North Richland Hills, TX United States
Atul Patil 1 Liège, Belgium
Thomas Gerner Jacobsen 1 Leuven, Belgium

Paul HAFEY 1 Keller, TX United States
Thomas Jacobsen 1 Liège, Belgium

Recent patent applications by HYLORIS DEVELOPMENTS S.A.

HYLORIS DEVELOPMENTS S.A. based in Liège, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-04-03 ✅ Patent 12,357,644 granted on 2025-07-15

US20250108063A1

Human necessities

ACETYL SALICYLIC ACID COMPOSITION FOR INTRAVENOUS ADMINISTRATION, ITS STORAGE, PRODUCTION AND USE

#2 | 2024-08-29 ✅ Patent 12,521,357 granted on 2026-01-13

US20240285559A1

Human necessities

INTRAVENOUS DOFETILIDE TO CONVERT ATRIAL FIBRILLATION/FLUTTER

#3 | 2024-08-01 ✅ Patent 12,343,320 granted on 2025-07-01

US20240252455A1

Human necessities

INTRAVENEOUS DOFETILIDE TO REDUCE THE RISK OF DEVELOPING AF/AFL POST CORONARY BYPASS SURGERY

#4 | 2023-01-19 ✅ Patent 12,121,520 granted on 2024-10-22

US20230018789A1

Human necessities

Metolazone emulsion formulation

#5 | 2021-11-11 ✅ Patent 11,957,648 granted on 2024-04-16

US20210346325A1

Human necessities

Method of initiating or escalating dofetilide dose and formulations therefor

#6 | 2021-11-04 ✅ Patent 11,413,241 granted on 2022-08-16

US20210338578A1

Human necessities

Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereof

#7 | 2020-06-11 ✅ Patent 11,389,451 granted on 2022-07-19

US20200179386A1

Human necessities

Metolazone emulsion formulation

#8 | 2019-07-25 ✅ Patent 11,666,532 granted on 2023-06-06

US20190224121A1

Human necessities

Tranexamic acid oral solution

Also check out Hyloris Developments SA's (Liège, Belgium) applicant profile with 14 patent applications submitted.

AssigneeID:

382709 ⎘